-
-
-
-
-
-
-
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering and Private Placement Priced at a Premium to Market Under Nasdaq Rules
-
-
-
21,302 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

